EP 4 - Kiran Mazumdar-Shaw says Biocon’s ALZUMAb drug will put India on the global map
Listen now
Description
Leadership Talks | Kiran Mazumdar-Shaw says Biocon’s ALZUMAb drug will put India on the global map. Biocon Founder Kiran Mazumdar-Shaw urges innovators to make more Made in India COVID-19 drugs and says she is proud of the biotech firm's ALZUMAb drug, which is helping save the lives of coronavirus patients.
Read more at: https://yourstory.com/video/leadership-talks-kiran-mazumdar-shaw
Follow us on Social Media:
Facebook: www.facebook.com/yourstorycom
Instagram: www.instagram.com/yourstory_com
Twitter: www.twitter.com/YourStoryCo
YouTube: www.youtube.com/yourstorytv
Write to us: [email protected]
This interview was originally hosted by Shradha Sharma on July 20, 2020. Presented by Julius Sharma!
More Episodes
In a conversation with Shradha Sharma, Founder and CEO of YourStory, Amitabh Chaudhry, CEO of Axis Bank, talks about leadership during COVID-19, business disruption, and how businesses can survive this pandemic.
Read more at:...
Published 05/24/21
In a world where people are constantly trying to change you, it takes courage to remain true to who you are. Nothing summarises Vidya Balan's journey as an actor than this E E Cummings quote. Listen to her fantastic story as she talks to YourStory's Shradha Sharma in this conversation that will...
Published 05/17/21
Bejul Somaia, Managing Director, Lightspeed Venture Partners, is known for making bold bets, investing early, and devoting his time to nurturing and coaching his entrepreneurs. In a conversation with YourStory Founder Shradha Sharma, Bejul talks investment strategies, founder-investor-fit, and...
Published 05/10/21
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
